Short Bio

The research activity of Dr. Alessandro Brancatella is aimed at studying the endocrinological complications induced by the new therapy with immune check-point inhibitors. His project is divided into a clinical part in which patients treated with immunotherapy are prospectively followed in order to understand the risk factors associated with the development of endocrine dysfunctions, and in a part of basic research aimed at the study of expression of the molecular targets of these drugs in endocrine tissues.

Publications

Brancatella A, Ricci D, Cappellani D, Viola N, Sgrò D, Santini F, Latrofa F. Is subacute thyroiditis an underestimated manifestation of SARS-CoV-2 infection?  Insights from a case series. J Clin Endocrinol Metab. 2020 Aug

Brancatella et al. Managment of thyrotoxicosis induced by PD1/PD-L1 blockade. Journal of Endocrine Society. 2021 May

Brancatella A, Ricci D, Viola N, Sgrò D, Santini F, Latrofa F. Subacute Thyroiditis After Sars-COV-2 Infection. J Clin Endocrinol Metab. 2020 Jul;105(7).

Ricci D, Brancatella A, Marinò M, Rotondi M, Chiovato L, Vitti P, Latrofa F. The Detection of Serum IgMs to Thyroglobulin in Subacute Thyroiditis Suggests a  Protective Role of IgMs in Thyroid Autoimmunity. J Clin Endocrinol Metab. 2020 Jun;105(6).

Ricci D, Brancatella A, Marinò M, Rotondi M, Chiovato L, Vitti P, Latrofa F. The Detection of Serum IgMs to Thyroglobulin in Subacute Thyroiditis Suggests a  Protective Role of IgMs in Thyroid Autoimmunity. J Clin Endocrinol Metab. 2020 Jun;105(6).

Lupi I, Brancatella A, Cetani F, Latrofa F, Kemp EH, Marcocci C. Activating Antibodies to The Calcium-sensing Receptor in Immunotherapy-induced  Hypoparathyroidism. J Clin Endocrinol Metab. 2020 May;105(5).

Lanzolla G, Ricci D, Nicolì F, Sabini E, Sframeli A, Brancatella A, Mantuano M, Dottore GR, Bucci I, Figus M, et al. Putative protective role of autoantibodies against the insulin-like growth factor-1  receptor in Graves’ Disease: results of a pilot study. J Endocrinol Invest. 2020 Jun;

Brancatella A, Mantovani G, Elli FM, Borsari S, Marcocci C, Cetani F. A severe inactivating PTH/PTHrP signaling disorder type 2 in a patient carrying a  novel large deletion of the GNAS gene: a case report and review of the literature. Endocrine. 2020 Feb;67(2):466–72.

Lupi I, Brancatella A, Cosottini M, Viola N, Lanzolla G, Sgrò D, Dalmazi G Di, Latrofa F, Caturegli P, Marcocci C. Clinical heterogeneity of hypophysitis secondary to PD-1/PD-L1 blockade: insights  from four cases. Endocrinol diabetes Metab case reports. 2019 Dec;2019.

Contacts

  • Lista Elementi #1
  • Lista Elementi #2